AI in Brief — Tuesday, 08 September 2026
Artificial intelligence was used to help develop rentosertib, a drug candidate for a rare lung condition, and early data suggests it may also slow biological hallmarks of aging. The drug's maker says the compound shows promise in addressing age-related decline, marking what could be the first practical demonstration of AI-assisted drug discovery yielding a candidate
AI in Brief — Tuesday, 08 September 2026 Read More »
